Primary CNS Lymphoma

Overview


Plain-Language Overview

Primary CNS Lymphoma is a rare type of cancer that starts in the brain or spinal cord, which are parts of the central nervous system. It involves the uncontrolled growth of abnormal lymphocytes, a type of white blood cell important for fighting infections. This condition mainly affects the brain's ability to function properly, leading to symptoms like headaches, confusion, weakness, or changes in vision. Because it occurs in the central nervous system, it can cause serious problems with movement, speech, and memory. Diagnosis often requires specialized imaging and tissue sampling to confirm the presence of cancerous cells. Treatment usually involves chemotherapy and sometimes radiation, aiming to control the tumor and improve neurological function.

Clinical Definition

Primary CNS Lymphoma is a highly aggressive non-Hodgkin lymphoma confined to the brain, spinal cord, leptomeninges, or eyes without systemic involvement at diagnosis. It is predominantly a diffuse large B-cell lymphoma arising from malignant transformation of B lymphocytes within the central nervous system. The pathogenesis involves immune dysregulation, often seen in immunocompromised patients such as those with HIV/AIDS or post-transplant immunosuppression, but it can also occur in immunocompetent individuals. Clinically, it presents with focal neurological deficits, neuropsychiatric symptoms, or signs of increased intracranial pressure. The disease is significant due to its rapid progression and poor prognosis without prompt treatment. Diagnosis and management require multidisciplinary care involving neurology, oncology, and pathology.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.